Prevalence of drug-resistant pulmonary tuberculosis in India: systematic review and meta-analysis
Vishal Goyal(Chandigarh University), Vikram Singh(Janssen (India)), Prashant Narang(Janssen (India)), Vijay Kadam(Maulana Azad National Urdu University)
Cited by 72
Related Papers
Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives
|Clinical Microbiology Reviews|2018|218
Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh
|PLoS neglected tropical diseases|2017|78
AmBisome Monotherapy and Combination AmBisome–Miltefosine Therapy for the Treatment of Visceral Leishmaniasis in Patients Coinfected With Human Immunodeficiency Virus in India: A Randomized Open-Label, Parallel-Arm, Phase 3 Trial
|Clinical Infectious Diseases|2022|53
Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial
|The Lancet. Gastroenterology & hepatology|2021|42
Long-term incidence of relapse and post-kala-azar dermal leishmaniasis after three different visceral leishmaniasis treatment regimens in Bihar, India
|PLoS neglected tropical diseases|2020|37